Latin America Small Business News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Small Business News.

Press releases published on August 28, 2026

Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome
MEXC Ventures Supports Alpha Arena Bali Final as Live DEMO Competition Crowns Its Champion
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million
ZMO Launches Innovative Crypto & Stock Trading Platform Powered by 1-Click Trading™
Tokio Marine HCC International Acquires Direct Commercial Limited, a Leading UK Commercial Motor MGA
STARCARES Completes Basketball Court Revamp in the Philippines, Benefiting Nearly 20,000 People
LUX Announces First Anniversary Under Creative Capital Ownership With Exclusive Gianan Wine Collaboration
Micware Group Reorganization Finalized
OSE Immunotherapeutics organisera un webcast dédié à lusvertikimab avec des leaders d’opinion le 2 septembre 2026
OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026
FLOVA PTE. LTD. Announces Full Integration of Seedance 2.5 into Flova.ai, Further Advancing Agent Native Video Production
Snail Games 于 Gamescom 2026 游戏展上蓄势待发:IP 拓展、内部研发与新作前瞻
Snail Games 在 Gamescom 2026 上重點展示 IP 擴展、內部開發及矚目新作
KeraFirm Pro Nail Formula Label Guide: What the Ingredient List, Application Directions, and Safety Statements Disclose for 2026
WIX FINAL DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Wix.com Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – WIX
MVST DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Microvast Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - MVST
CRTO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Criteo S.A.
INV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Innventure, Inc.
HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Latin America Small Business News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.